Glucagon-like peptide-1 analog (Radboud University)

N/A

Report date: 2023/06/26 09:15:41
NME

Base Information

Drug NameGlucagon-like peptide-1 analog (Radboud University)
Drug Alias Nameglucagon-like peptide-1 analog111-In-labeled GLP-1 analog DTPA-[K40]-exendin 4
ClassificationSmall molecules > Synthetic peptideDiagnostic agent (In vivo)
Mechanisms of ActionGlucagon-like peptide 1 receptor antagonistsPositron-emission tomography enhancers
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRadboud University Nijmegen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRadboud University Medical Center
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A